These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34261897)

  • 1. Managing abnormal liver tests in children with inflammatory bowel disease.
    van Rheenen PF
    Curr Opin Pediatr; 2021 Oct; 33(5):521-529. PubMed ID: 34261897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    DeFilippis EM; Kumar S
    Dig Dis Sci; 2015 Oct; 60(10):2873-80. PubMed ID: 25999245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Complications of Inflammatory Bowel Disease.
    Mahfouz M; Martin P; Carrion AF
    Clin Liver Dis; 2019 May; 23(2):191-208. PubMed ID: 30947871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
    World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
    Lee WS; Karthik SV; Ng RT; Ong SY; Ong C; Chiou FK; Wong SY; Quak SH; Aw MM
    Pediatr Neonatol; 2019 Aug; 60(4):396-404. PubMed ID: 31409456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Massironi S; Pirola L; Mulinacci G; Ciaccio A; Viganò C; Palermo A; Zilli A; Invernizzi P; Danese S
    Inflamm Bowel Dis; 2023 Sep; 29(9):1477-1487. PubMed ID: 36040402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases.
    Núñez Figueroa P; Sedano Muñoz R; Quera Pino R; Carrasco-Avino G; O Brien A; Brahm Barril J
    Rev Esp Enferm Dig; 2020 Oct; 112(10):788-791. PubMed ID: 32954772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing Cholangitis in Children and Adolescents.
    Mieli-Vergani G; Vergani D
    Clin Liver Dis; 2016 Feb; 20(1):99-111. PubMed ID: 26593293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.
    Kerkar N; Chan A
    Clin Liver Dis; 2018 Nov; 22(4):689-702. PubMed ID: 30266157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
    Kemme S; Mack CL
    Pediatr Clin North Am; 2021 Dec; 68(6):1293-1307. PubMed ID: 34736590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing cholangitis: pediatric perspective.
    Kerkar N; Miloh T
    Curr Gastroenterol Rep; 2010 Jun; 12(3):195-202. PubMed ID: 20425475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE; Janse M; Haagsma EB; van den Berg AP; Weersma RK
    Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic manifestations of inflammatory bowel diseases.
    Restellini S; Chazouillères O; Frossard JL
    Liver Int; 2017 Apr; 37(4):475-489. PubMed ID: 27712010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
    Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
    Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSC, AIH and overlap syndrome in inflammatory bowel disease.
    Trivedi PJ; Chapman RW
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):420-36. PubMed ID: 22306055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome complicated by inflammatory bowel disease.
    Lamia S; Sana K; Rachid J; Hajer A; Leila M; Nabil T; Mongia H
    Tunis Med; 2012 Dec; 90(12):899-900. PubMed ID: 23247795
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatobiliary manifestations of inflammatory bowel disease.
    Yarur AJ; Czul F; Levy C
    Inflamm Bowel Dis; 2014 Sep; 20(9):1655-67. PubMed ID: 24874461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Extrahepatic Disorders in Patients With Autoimmune Liver Disease.
    Contreras GV; Marugan MT; Cuervas-Mons V
    Transplant Proc; 2021 Nov; 53(9):2695-2697. PubMed ID: 34593249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.